Trevi Therapeutics (TRVI) Other Accumulated Expenses (2018 - 2026)
Trevi Therapeutics (TRVI) posted Other Accumulated Expenses of $130,000 for Q2 2026, compared with $11,000 a year earlier and up 4.8% from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Trevi Therapeutics' Other Accumulated Expenses came in at $184,000, up 327.9% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In prior years, Trevi Therapeutics' Other Accumulated Expenses was $43,000 in FY2024 (+616.7%), $6,000 in FY2023 (-98.8%), $498,000 in FY2022 (+530.4%) and $79,000 in FY2021 (-50.0%).
- Quarterly Other Accumulated Expenses has run from a low of $6,000 in Q4 2023 to a high of $498,000 in Q4 2022 over five years.
- On a year-over-year basis, Other Accumulated Expenses increased in five of the last seven quarters, with growth averaging 158.4%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2024, with growth of 616.7%; the weakest was Q4 2023, with a decline of 98.8%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $124,000 (Q1 2026), $184,000 (Q4 2025) and $126,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Trevi Therapeutics | 1.98 Bn | 1.98 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 130,000.00 |
| Mar 31, 2026 | 124,000.00 |
| Dec 31, 2025 | 184,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 467,000.00 |
| Dec 31, 2022 | 498,000.00 |
| Sep 30, 2022 | 415,000.00 |
| Jun 30, 2022 | 332,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 79,000.00 |
| Sep 30, 2021 | 70,000.00 |
API Access
Trevi Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();